Imatinib mesylate reduces c-MYC expression in double-hit lymphoma cells by suppressing inducible cytidine deaminase
Journal of Cancer Research and Clinical Oncology · 2024
DOI: 10.1007/s00432-024-05939-4 ↗At a glance
Journal article in Journal of Cancer Research and Clinical Oncology, 2024. Written by JingCheng Zhang and 5 co-authors. Institution: Department of Hematology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, 321000, China. Major MEDLINE topics: Imatinib Mesylate, Cytidine Deaminase, Proto-Oncogene Proteins c-myc, Xenograft Model Antitumor Assays. Cited 1 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Niciun rezumat disponibil.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Hematology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, 321000, China.
- Department of Hematology, Lanxi People's Hospital, Lanxi, 321100, China.
- Department of Internal Medicine, Yongkang Traditional Chinese Medicine Hospital, Yongkang, 321000, China.
- Department of Hematology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, 321000, China. huhuixian@zju.edu.cn.
Cite
APA
Zhang, J., Zhou, S., Jiang, S., He, F., Tu, Y., & Hu, H. (2024). Imatinib mesylate reduces c-MYC expression in double-hit lymphoma cells by suppressing inducible cytidine deaminase. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05939-4
Vancouver
Zhang J, Zhou S, Jiang S, He F, Tu Y, Hu H. Imatinib mesylate reduces c-MYC expression in double-hit lymphoma cells by suppressing inducible cytidine deaminase. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05939-4
BibTeX
@article{Zhang2024,
author = {Zhang, JingCheng and Zhou, Sheng and Jiang, SiSi and He, Fang and Tu, Yan and Hu, HuiXian},
title = {Imatinib mesylate reduces c-MYC expression in double-hit lymphoma cells by suppressing inducible cytidine deaminase},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
doi = {10.1007/s00432-024-05939-4}
}
EUVIMED